DURHAM, N.C.--(BUSINESS WIRE)--Apr 1, 2024--
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI’s expertise in Quality and Regulatory Affairs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240401053397/en/
A highly respected and successful industry leader, Peter brings over 35 years of experience in operations, quality, and technology leadership in a diverse range of areas in the life sciences spectrum, including biotechnology, pharmaceuticals, and advanced therapies. Peter will lead KBI’s Quality and Regulatory Affairs team, spearheading compliance and regulatory initiatives for customers worldwide and positioning KBI to provide the services, expertise, and leadership to partner with health authorities on regulatory policy.
"We have made a commitment to establishing KBI Biopharma as a thought leader and catalyst for change in Regulatory Affairs within the biopharma sector,” said J.D. Mowery, President & CEO of KBI Biopharma. "Peter's addition to our team bolsters our expertise in quality and regulatory compliance and facilitates our continued transformation in support of our current and future customers. His passion for making a difference in the world, coupled with his drive to develop and deliver innovative products that improve patients’ lives, makes him an invaluable asset to KBI.”
“I am thrilled to join KBI Biopharma during a time of significant evolution for the company,” said Peter Carbone, Chief Quality Officer of KBI Biopharma. “We are poised for remarkable advancements in the biopharma industry, and I look forward to working with this talented team to drive innovation, ensure quality, deliver exceptional results, and ultimately make a meaningful impact on patients’ lives worldwide.”
Prior to joining KBI, Peter led engineering, operations, and quality organizations at major pharmaceutical companies, including Bayer, Amgen, Allergan, Novartis, Acorda, and the Center of Breakthrough Medicines. He holds a BS in Chemical Engineering from Rensselaer Polytechnic Institute.
About KBI Biopharma, Inc.
KBI Biopharma, Inc., a JSR Life Sciences company, together with its affiliates, is a global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. As a global leader in mammalian cell line development, with best-in-class modular technology and highly specialized solutions, KBI enables the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. With each of its 500+ client partners, KBI works closely to personalize and rapidly accelerate drug development programs.
Global partners are utilizing KBI’s technologies to advance more than 160 drug candidates in preclinical and clinical development and the manufacture of ten commercial products. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, KBI delivers robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, KBI helps partners advance drug candidates to the market. KBI serves its global partners with eight locations in Europe and the USA. More information is available at www.kbibiopharma.com.
Peter Carbone, KBI Biopharma Chief Quality Officer (Photo: Business Wire)
INDIANAPOLIS (AP) — Indiana Fever rookie Caitlin Clark learned some tough lessons from her first two WNBA tests.
She's struggled with fouls, expectations and, like most rookies, making a smooth transition from college ball to the pro level. And, here, there's no grading curve, as Clark found out Thursday night.
Two-time league MVP Breanna Stewart ruined Clark's regular season home debut by scoring 31 points to lead the New York Liberty to a 102-66 win in front of a sellout crowd of 17,247.
“I think this is how you want everything to be, you want a sellout crowd like this,” Stewart said. “It gives you a little bit of a playoff atmosphere feel because usually in the playoffs, the games are sold out. We might be changing our terminology if we're just going to continue to set the precedent of sellouts home or away."
Clark's presence has changed everything about the women's sport — except the wins and losses for Indiana, which hasn't made the playoffs since 2016 is now 0-2 in the Clark era.
This game was Indianapolis' most anticipated rookie debut since Peyton Manning with the NFL's Indianapolis Colts in 1998, but things didn't go according to plan and.
She picked up three fouls in the first half and a fourth early in the third quarter. When Clark went to bench early in the second quarter, she took out her frustrations on a towel and at one point after a Fever miscue she flipped the ball over her head to the ref.
Clark finished with nine points, seven rebounds and six assists and showed some progress by finishing with three turnovers — none after the first quarter — and a dramatic improvement over the 10 she had in Tuesday night's season opener. Clark also was 2 of 8 from the field and just 1 of 7 on 3-pointers.
“I have great perspective of on everything and I think the same is true of my college career,” she said before the game. "There were some moments that were absolutely amazing and there were some moments where I was not happy with how I played and how I performed and how my team performed. But that’s just life. That’s just basketball.”
Clark did not speak with reporters after the game though she did two lengthy interview sessions earlier Thursday.
Sabrina Ionescu and Jonquel Jones each scored 14 for New York, which has won eight straight over Indiana. Jones also had 10 rebounds.
Aliyah Boston had a game-high 12 points and seven rebounds, and the Fever came away looking to do more to help Clark.
“People are playing her aggressively and we can do a better job of trying to help her get some space and get free,” Indiana forward Katie Lou Samuelson said. “We want her to keep fighting. We want to keep figuring out the best way to work with her and, like I said, I think we can continue to help her.”
The Liberty didn't just make life difficult for Clark, they made things tough for Indiana.
Stewart helped New York seize control by taking a 25-16 lead after one quarter. And when the Fever cut the deficit to 32-27 midway through the second quarter, Stewart answered with four straight points to spur a 12-0 run that gave the Liberty a 44-27 cushion late in the first half.
Indiana finally responded by closing the third quarter with 12 straight points, the first seven coming courtesy of Clark, to make it 67-56 after three.
But the defending Eastern Conference champs opened the fourth quarter on a 12-0 spurt and cruised to their second straight victory.
Indianapolis is quickly becoming a favorite destination for Clark's former teammates and coaches. Ex-Hawkeyes guard Gabbie Marshall showed up and posed for a photo with her longtime friend following Clark's first home preseason game last week.
On Thursday, the entourage included former coach, Lisa Bluder, who announced her retirement Monday, and new Hawkeyes coach, Jan Jensen — Bluder's longtime assistant.
The Fever and Liberty head back to New York on Saturday for a rematch.
AP WNBA: https://apnews.com/hub/wnba-basketball
Indiana Fever guard Caitlin Clark warms up before a WNBA basketball game against the New York Liberty, Thursday, May 16, 2024, in Indianapolis. (AP Photo/Michael Conroy)
Fans watch Indiana Fever guard Caitlin Clark warm up for the team's WNBA basketball game against the New York Liberty, Thursday, May 16, 2024, in Indianapolis. (AP Photo/Michael Conroy)
A person watches Indiana Fever guard Caitlin Clark warm up for the team's basketball game against the New York Liberty, Thursday, May 16, 2024, in Indianapolis. (AP Photo/Michael Conroy)
Fans watch Indiana Fever guard Caitlin Clark warm up for the team's WNBA basketball game against the New York Liberty, Thursday, May 16, 2024, in Indianapolis. (AP Photo/Michael Conroy)
